A research on seven top pharmaceutical companies has provided fresh data about costs of clinical trials:
For the trials in the data set, the median cost of conducting a study from protocol approval to final clinical trial report was US$3.4 million for phase I trials involving patients, $8.6 million for phase II trials and $21.4 million for phase III trials.If you compare these data with the total drug costs (2.6 billion), you may ask yourself how all these costs are estimated. Maybe all this information is wrong and useless.
PS. Waiting for the new book on Theranos scandal
Pharma sales 2017
Kupka au Grand Palais
